Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

NCT06353906 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Netherlands Cancer Institute

Collaborators